PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor

被引：0
|
作者：
Jiang, J. [1 ]
Shi, L. [1 ]
Chen, L. [1 ]
Zhu, Y. [1 ]
Wu, C. [1 ]
Lu, B. [2 ]
机构：
[1] Soochow Univ, Dept Tumor Biol Treatment, Affiliated Hosp 3, Changzhou, Peoples R China
[2] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15213 USA
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2016年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
183
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [31] Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade
    Wang, Shuhang
    Yuan, Pei
    Mao, Beibei
    Li, Ning
    Ying, Jianming
    Tao, Xiuli
    Tang, Wei
    Zhang, Lei
    Geng, Xiao
    Zhang, Fan
    Xue, Qi
    Wu, Lijia
    Zhang, Henghui
    Gao, Shugeng
    He, Jie
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)
  • [32] In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
    Bartee, Eric
    Li, Zihai
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [33] In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
    Eric Bartee
    Zihai Li
    Experimental Hematology & Oncology, 6
  • [34] Blockade of PD-1 and PD-L1 restores defective innate immune responses in leukocytes from septic humans
    Ward, Peter A.
    Fattahi, Fatemeh
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1229 - 1231
  • [35] Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy
    Wu, Suying
    Wu, Zhouliang
    Lu, Zefang
    Qi, Feilong
    Cheng, Jin
    Chu, Tianjiao
    Li, Bozhao
    Zhao, Yuliang
    Nie, Guangjun
    Li, Suping
    CELL REPORTS MEDICINE, 2025, 6 (03)
  • [36] Immune signatures of second-line PD-1 immune checkpoint blockade
    O'Byrne, K. J.
    Monkman, J.
    Mehdi, A.
    Matigian, N.
    Kulasinghe, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1007 - S1007
  • [37] Immune microenvironment controls the outcome of PD-1 blockade in cutaneous immune response
    Ogawa, Tatsuya
    Ishitsuka, Yosuke
    Saito, Akimasa
    Nakamura, Yoshiyuki
    Watanabe, Rei
    Okiyama, Naoko
    Fujisawa, Yasuhiro
    Fujimoto, Manabu
    ALLERGY, 2019, 74 (11) : 2257 - 2261
  • [38] Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses
    Bu, Xia
    Juneja, Vikram R.
    Reynolds, Carol G.
    Mahoney, Kathleen M.
    Bu, Melissa T.
    McGuire, Kathleen A.
    Maleri, Seth
    Hua, Ping
    Zhu, Baogong
    Klein, Sarah R.
    Greenfield, Edward A.
    Armand, Philippe
    Ritz, Jerome
    Sharpe, Arlene H.
    Freeman, Gordon J.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (12) : 1465 - 1475
  • [39] Toward better selection of PD-1 blockade responders through direct markers of adaptive immune resistance
    Shin, Daniel S.
    Garcia-Diaz, Angel
    Escuin-Ordinas, Helena
    Palaskas, Nicolaos J.
    Komenan, Sara M.
    Graeber, Thomas G.
    Comin-Anduix, Begonya
    Ribas, Antoni
    CANCER RESEARCH, 2015, 75
  • [40] INTESTINAL MICROBIAL FUNCTIONAL CONTENT BETTER DEFINES THERAPEUTIC RESPONSES TO IMMUNE CHECKPOINT PD-1 BLOCKADE
    Gharaibeh, Raad Z.
    da Silva, Wildson Vieira
    Newsome, Rachel
    Paul, Shirlene
    Hogue, Stephanie
    Bowles, Kristina
    Robinson, Lary
    Antonia, Scott J.
    Conejo-Garcia, Jose
    Pierce, Christine
    Jobin, Christian
    GASTROENTEROLOGY, 2019, 156 (06) : S2 - S2
12345